Erin Wright

Stock Analyst at Morgan Stanley

(4.44)
# 339
Out of 5,044 analysts
238
Total ratings
64.12%
Success rate
13.39%
Average return

Stocks Rated by Erin Wright

Align Technology
Oct 21, 2025
Maintains: Equal-Weight
Price Target: $154$142
Current: $133.14
Upside: +6.65%
Option Care Health
Oct 17, 2025
Initiates: Overweight
Price Target: $35
Current: $28.20
Upside: +24.11%
Molina Healthcare
Oct 14, 2025
Maintains: Equal-Weight
Price Target: $163$204
Current: $162.84
Upside: +25.28%
Elevance Health
Oct 14, 2025
Maintains: Equal-Weight
Price Target: $316$359
Current: $339.40
Upside: +5.77%
CVS Health
Oct 14, 2025
Maintains: Overweight
Price Target: $82$89
Current: $82.20
Upside: +8.27%
BrightSpring Health Services
Oct 14, 2025
Maintains: Overweight
Price Target: $25$32
Current: $34.00
Upside: -5.88%
Phillips 66
Oct 3, 2025
Maintains: Equal-Weight
Price Target: $128$140
Current: $133.66
Upside: +4.74%
McKesson
Sep 24, 2025
Maintains: Overweight
Price Target: $810$857
Current: $804.59
Upside: +6.51%
IDEXX Laboratories
Aug 15, 2025
Maintains: Overweight
Price Target: $722$765
Current: $634.36
Upside: +20.59%
Envista Holdings
Aug 1, 2025
Maintains: Equal-Weight
Price Target: $16$17
Current: $20.06
Upside: -15.25%
Maintains: Equal-Weight
Price Target: $290$277
Current: $294.80
Upside: -6.04%
Maintains: Equal-Weight
Price Target: $313$330
Current: $335.64
Upside: -1.68%
Maintains: Overweight
Price Target: $181$190
Current: $162.79
Upside: +16.71%
Maintains: Equal-Weight
Price Target: $21$26
Current: $41.68
Upside: -37.62%
Maintains: Overweight
Price Target: $379$390
Current: $308.41
Upside: +26.46%
Maintains: Underweight
Price Target: $3.5$3.2
Current: $2.57
Upside: +24.51%
Maintains: Equal-Weight
Price Target: $14$13
Current: $22.12
Upside: -41.23%
Maintains: Overweight
Price Target: $243$238
Current: $145.41
Upside: +63.68%
Maintains: Overweight
Price Target: $30$23
Current: $13.07
Upside: +75.98%
Upgrades: Overweight
Price Target: $145$172
Current: $178.28
Upside: -3.52%
Maintains: Underweight
Price Target: $69$65
Current: $63.21
Upside: +2.83%
Reiterates: Overweight
Price Target: $587
Current: $367.84
Upside: +59.58%
Assumes: Overweight
Price Target: $300
Current: $259.69
Upside: +15.52%
Maintains: Outperform
Price Target: $39$42
Current: $15.08
Upside: +178.51%
Maintains: Outperform
Price Target: $282$288
Current: $216.90
Upside: +32.78%
Maintains: Neutral
Price Target: $342$352
Current: $187.93
Upside: +87.30%
Maintains: Outperform
Price Target: $42$44
Current: $3.23
Upside: +1,262.23%
Maintains: Outperform
Price Target: $178$181
Current: $580.53
Upside: -68.82%
Maintains: Neutral
Price Target: $14$17
Current: $57.33
Upside: -70.35%
Maintains: Outperform
Price Target: $104$121
Current: $34.16
Upside: +254.22%
Maintains: Outperform
Price Target: $556$580
Current: $557.63
Upside: +4.01%
Initiates: Neutral
Price Target: $35
Current: $12.13
Upside: +188.54%
Maintains: Outperform
Price Target: $181$205
Current: $177.73
Upside: +15.34%
Maintains: Neutral
Price Target: $12$11
Current: $23.43
Upside: -53.05%
Maintains: Outperform
Price Target: $175$157
Current: $218.13
Upside: -28.02%
Maintains: Outperform
Price Target: $42$38
Current: $28.18
Upside: +34.85%
Maintains: Underperform
Price Target: $31$17
Current: $5.28
Upside: +221.97%
Maintains: Neutral
Price Target: $300$308
Current: $485.77
Upside: -36.60%